• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Evaluation of Blood Pressure Control and Associated Factors among Patients with Hypertension in Iraq: A Prospective Cross-sectional Study.伊拉克高血压患者血压控制及相关因素评估:一项前瞻性横断面研究。
J Pharm Bioallied Sci. 2019 Jul-Sep;11(3):232-239. doi: 10.4103/jpbs.JPBS_82_19.
2
Target blood pressure attainment in diabetic hypertensive patients: need for more diuretics?糖尿病高血压患者的目标血压达标:是否需要更多利尿剂?
Int J Clin Pharmacol Ther. 2009 Jul;47(7):434-8. doi: 10.5414/cpp47434.
3
Blood Pressure Control and Prescription Pattern of Antihypertensive Drugs in Adherence to the 2020 International Society of Hypertension (ISH) Global Hypertension Practice Guidelines in Saudi Arabia: A Retrospective Study.沙特阿拉伯遵循2020年国际高血压学会(ISH)全球高血压实践指南的血压控制及抗高血压药物处方模式:一项回顾性研究
Cureus. 2023 Feb 14;15(2):e34965. doi: 10.7759/cureus.34965. eCollection 2023 Feb.
4
The impact of pay for performance on the control of blood pressure in people with chronic kidney disease stage 3-5.绩效薪酬对 3-5 期慢性肾脏病患者血压控制的影响。
Nephrol Dial Transplant. 2013 Aug;28(8):2107-16. doi: 10.1093/ndt/gft093. Epub 2013 May 7.
5
Medical treatment of hypertension in Switzerland. The 2009 Swiss Hypertension Survey (SWISSHYPE).瑞士的高血压治疗。2009 年瑞士高血压调查(SWISSHYPE)。
Swiss Med Wkly. 2011 Mar 4;141:w13169. doi: 10.4414/smw.2011.13169. eCollection 2011.
6
HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.土耳其的HYT高血压:关于单独使用钙通道阻滞剂或与其他抗高血压药物联合使用时血压控制情况的横断面调查
High Blood Press Cardiovasc Prev. 2015 Jun;22(2):165-72. doi: 10.1007/s40292-015-0091-6. Epub 2015 Apr 22.
7
Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.尼日利亚一家三级医院高血压药物治疗的趋势变化:对新旧抗高血压药物的疗效、安全性、合理性和药物经济学的真实世界评估
J Hum Hypertens. 2003 Apr;17(4):277-85. doi: 10.1038/sj.jhh.1001538.
8
9
Time trends in high blood pressure control and the use of antihypertensive medications in older adults: the Cardiovascular Health Study.老年人高血压控制及抗高血压药物使用的时间趋势:心血管健康研究
Arch Intern Med. 2002 Nov 11;162(20):2325-32. doi: 10.1001/archinte.162.20.2325.
10

引用本文的文献

1
Prevalence of dyslipidemia and its association with blood pressure control in Iranian hypertensive patients: insights from STEPS 2021.伊朗高血压患者血脂异常的患病率及其与血压控制的关系:来自2021年全球成人烟草调查(STEPS)的见解
Lipids Health Dis. 2025 Jul 7;24(1):232. doi: 10.1186/s12944-025-02660-0.
2
Prevalence of hypertension links with body mass index by academic population in Babylon city.巴比伦市学术人群中高血压患病率与体重指数的关联
J Adv Pharm Technol Res. 2023 Apr-Jun;14(2):133-136. doi: 10.4103/japtr.japtr_106_23. Epub 2023 Apr 13.
3
Disparities in Prevalence and Barriers to Hypertension Control: A Systematic Review.高血压控制的患病率和障碍差异:系统评价。
Int J Environ Res Public Health. 2022 Nov 6;19(21):14571. doi: 10.3390/ijerph192114571.
4
Management of Diabetes and Hypertension within the Gulf Region: Updates on Treatment Practices and Therapies.海湾地区糖尿病与高血压的管理:治疗实践与疗法的最新进展
Diabetes Ther. 2022 Jul;13(7):1253-1280. doi: 10.1007/s13300-022-01282-4. Epub 2022 Jun 9.
5
Implementing Single-Pill Combination Therapy for Hypertension: A Scoping Review of Key Health System Requirements in 30 Low- and Middle-Income Countries.实施高血压单片复方制剂治疗:30 个中低收入国家关键卫生系统需求的范围综述。
Glob Heart. 2022 Jan 25;17(1):6. doi: 10.5334/gh.1087. eCollection 2022.
6
Associations between Socio-Demographic Factors and Hypertension Management during the COVID-19 Pandemic: Preliminary Findings from Malaysia.社会人口因素与 COVID-19 大流行期间高血压管理的关系:来自马来西亚的初步发现。
Int J Environ Res Public Health. 2021 Sep 3;18(17):9306. doi: 10.3390/ijerph18179306.

本文引用的文献

1
Prevalence, control and risk factors related to hypertension among Moroccan adults: a multicentre study.摩洛哥成年人高血压的患病率、控制率及相关危险因素:一项多中心研究。
East Mediterr Health J. 2019 Oct 4;25(7):447-456. doi: 10.26719/emhj.18.057.
2
Evaluating the feasibility of a pharmacist-guided patient-driven intervention to improve blood pressure control in patients with CKD.评估由药剂师指导的患者驱动干预措施改善慢性肾脏病患者血压控制的可行性。
Pilot Feasibility Stud. 2019 Feb 12;5:23. doi: 10.1186/s40814-019-0410-0. eCollection 2019.
3
Adverse effects and non-adherence to antihypertensive medications in University of Gondar Comprehensive Specialized Hospital.贡德尔大学综合专科医院抗高血压药物的不良反应及服药依从性
Clin Hypertens. 2019 Jan 15;25:1. doi: 10.1186/s40885-018-0104-6. eCollection 2019.
4
Intensive Blood Pressure Treatment for Resistant Hypertension.强化降压治疗难治性高血压。
Hypertension. 2019 Feb;73(2):415-423. doi: 10.1161/HYPERTENSIONAHA.118.12156.
5
Magnitude and determinants of uncontrolled blood pressure among hypertensive patients in Ethiopia: hospital-based observational study.埃塞俄比亚高血压患者中血压未得到控制的程度及决定因素:一项基于医院的观察性研究。
Pharm Pract (Granada). 2018 Apr-Jun;16(2):1173. doi: 10.18549/PharmPract.2018.02.1173. Epub 2018 Jun 22.
6
Combination therapy in the treatment of hypertension.高血压治疗中的联合疗法。
Drugs Context. 2018 Jun 6;7:212531. doi: 10.7573/dic.212531. eCollection 2018.
7
Hypertension.高血压。
Nat Rev Dis Primers. 2018 Mar 22;4:18014. doi: 10.1038/nrdp.2018.14.
8
Hypertension with diabetes mellitus: physiology and pathology.高血压合并糖尿病:生理学和病理学。
Hypertens Res. 2018 Jun;41(6):389-393. doi: 10.1038/s41440-018-0034-4. Epub 2018 Mar 19.
9
Assessment of blood pressure control in adult hypertensive patients in eastern Sudan.苏丹东部成年高血压患者血压控制情况评估
BMC Cardiovasc Disord. 2018 Feb 7;18(1):26. doi: 10.1186/s12872-018-0769-5.
10
Is early and fast blood pressure control important in hypertension management?高血压管理中早期快速血压控制是否重要?
Int J Cardiol. 2018 Mar 1;254:328-332. doi: 10.1016/j.ijcard.2017.12.026. Epub 2017 Dec 13.

伊拉克高血压患者血压控制及相关因素评估:一项前瞻性横断面研究。

Evaluation of Blood Pressure Control and Associated Factors among Patients with Hypertension in Iraq: A Prospective Cross-sectional Study.

作者信息

Nassr Ola Ali, Forsyth Paul

机构信息

Department of Clinical Pharmacy, College of Pharmacy, Mustansiriya University, Baghdad, Iraq.

NHS Greater Glasgow and Clyde, Pharmacy Services, Clarkston Court, Scotland, United Kingdom.

出版信息

J Pharm Bioallied Sci. 2019 Jul-Sep;11(3):232-239. doi: 10.4103/jpbs.JPBS_82_19.

DOI:10.4103/jpbs.JPBS_82_19
PMID:31555029
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6662046/
Abstract

BACKGROUND

Uncontrolled blood pressure (BP) is a major contributor to cardiovascular disease-related morbidity and mortality. However, evidence regarding the rate and factors associated with uncontrolled BP in Iraq is scarce. The objectives of this study were a) to assess the magnitude of and factors associated with patient BP control and b) to investigate the patient-level prescribing patterns of antihypertensive medications, in a large Iraqi hospital.

MATERIALS AND METHODS

A prospective, cross-sectional study was conducted in the primary care centers of Al-Yarmouk Hospital in Baghdad, Iraq, between April 2018 and August 2018. Eligible patients answered standard survey questions and had their BP measured. Controlled BP was defined as <130/80mm Hg for patients with diabetes and/or chronic kidney disease and <140/90mm Hg for other populations.

RESULTS

During the study period, 300 patients were included; of which, 67.3% were female. The average age was 57.6 (9.2) years (range, 25-79 years). Among the 300 patients included, only 38.7% had controlled BP. In univariate analysis, poorly controlled BP was not associated with education, employment, smoking, comorbid conditions excluding diabetes, and therapeutic regimen used. In contrast, the strongest predictors of uncontrolled BP were age <60 years, male sex, and diabetes mellitus. The majority were prescribed monotherapy (53.0%), followed by dual therapy (38.7%), and triple therapy (8.3%). Angiotensin II receptor blockers or angiotensin-converting enzyme inhibitors were the most commonly prescribed medications at 74.7%, followed by beta-blockers at 29.3%, calcium channel blockers at 28.0%, and diuretics at 23.0%.

CONCLUSION

BP control was suboptimal. Effective feasible strategies should be implemented to increase BP control in Iraq to reduce hypertension-related complications.

摘要

背景

血压不受控制是心血管疾病相关发病和死亡的主要原因。然而,关于伊拉克血压不受控制的发生率及相关因素的证据很少。本研究的目的是:a)评估患者血压控制的程度及相关因素;b)调查伊拉克一家大型医院中患者层面的抗高血压药物处方模式。

材料与方法

2018年4月至2018年8月期间,在伊拉克巴格达的亚尔穆克医院初级保健中心进行了一项前瞻性横断面研究。符合条件的患者回答标准调查问卷问题并测量血压。糖尿病和/或慢性肾脏病患者的血压控制定义为<130/80mmHg,其他人群为<140/90mmHg。

结果

研究期间纳入300例患者;其中67.3%为女性。平均年龄为57.6(9.2)岁(范围25 - 79岁)。在纳入的300例患者中,只有38.7%的患者血压得到控制。单因素分析中,血压控制不佳与教育程度、就业情况、吸烟、除糖尿病外的合并症以及所用治疗方案无关。相比之下,血压不受控制的最强预测因素是年龄<60岁、男性和糖尿病。大多数患者接受单药治疗(53.0%),其次是联合治疗(38.7%)和三联治疗(8.3%)。血管紧张素II受体阻滞剂或血管紧张素转换酶抑制剂是最常用的药物,占74.7%,其次是β受体阻滞剂,占29.3%,钙通道阻滞剂占28.0%,利尿剂占23.0%。

结论

血压控制不理想。应实施有效的可行策略以提高伊拉克的血压控制水平,从而减少高血压相关并发症。